Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer

Inclusion Criteria: * histologically proven non-small cell lung cancer * inoperable Stage III A or B NSCLC * must have measurable disease by RECIST criteria * no more than one prior chemotherapy for advanced disease * ECOG Performance Status of 0, 1, or 2 * must be able to swallow pills or have a working gastric feeding tube and no evidence of malabsorption * negative serum beta-HCG test and under active contraception (for females of childbearing potential) * no known allergies to any of the study drugs * willingness to sign an informed consent Exclusion Criteria: * women who are pregnant or breastfeeding * ANC of less than 1500/mm3 * platelet count of less than 100,000/mm3 * estimated creatinine clearance of less than 50 cc/min (as measured by the Cockcroft-Gault equation) * bilirubin of less than 2mg/dl * SGPT of greater than 2x nl * peripheral neuropathy of Grade 2 or higher * more than one previous chemotherapy and previous radiation therapy to the chest * a history of CHF/MI or other significant cardiac history within the last six months